Axim Biotechnologies Inc AXIM:OTCQB

*Data is delayed | Exchange | USD
Last | 03/27/24 EDT
0.0119UNCH (UNCH)
52 week range
0.01 - 0.05
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0119
  • 52 Week High0.05
  • 52 Week High Date04/13/23
  • 52 Week Low0.01
  • 52 Week Low Date03/27/24

Key Stats

  • Market Cap2.828M
  • Shares Out237.65M
  • 10 Day Average Volume568,645.1
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-37.37

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0119
  • 52 Week High0.05
  • 52 Week High Date04/13/23
  • 52 Week Low0.01
  • 52 Week Low Date03/27/24
  • Market Cap2.828M
  • Shares Out237.65M
  • 10 Day Average Volume568,645.1
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-37.37

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-0.39
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-2.712M
  • ROE (TTM)-10,023.00%
  • Revenue (TTM)34,469.999
  • Gross Margin (TTM)53.49%
  • Net Margin (TTM)-20,471.45%
  • Debt To Equity (MRQ)-93.34%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Axim Biotechnologies Inc

 

Profile

MORE
Axim Biotechnologies, Inc. is an international healthcare diagnostic solutions development company. The Company is focused on improving the landscape for the diagnosis of ophthalmological conditions such as dry eye disease (DED) through rapid diagnostic tests. It has developed and commercialized two highly specialized point-of-care (POC) diagnostic tests, Ocular Immunoglobulin E (IgE) test and Lactoferrin test, which are designed specifically to assist eye-care physicians in...
John Huemoeller II
President, Chief Executive Officer, Director
Kurt Phinney
Chief Operating Officer
Robert Malasek
Chief Financial Officer, Company Secretary
Address
6191 Cornerstone Court, E, Suite 114
San Diego, CA
92121
United States